CIAOMed Roundtable: Lupus Experts Predict More Use of RA Drugs, Seek Biomarkers to Speed Clinical Trials
Monday, April 23, 2007
CIAOMed's "Virtual Roundtable" of lupus experts identified drugs borrowed from other areas of rheumatology as the most important recent advances in treatment of systemic lupus erythematosus (SLE) and emphasized the need for reliable biomarkers as the major rate-limiting factor in SLE clinical research.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms